85 related articles for article (PubMed ID: 31174615)
1. Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers.
Marconato L; Aresu L; Stefanello D; Comazzi S; Martini V; Ferrari R; Riondato F; Rouquet N; Frayssinet P; Sabattini S
J Immunother Cancer; 2019 Jun; 7(1):146. PubMed ID: 31174615
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of peripheral blood and bone marrow infiltration assessed by flow cytometry in dogs with de novo nodal peripheral T-cell lymphoma receiving alkylating-rich chemotherapy.
Marconato L; Comazzi S; Agnoli C; Aresu L; Stefanello D; Riondato F; Gamberini L; Sabattini S
Vet J; 2024 Feb; 303():106057. PubMed ID: 38086438
[TBL] [Abstract][Full Text] [Related]
3. Long-term remission and survival in dogs with high-grade, B cell lymphoma treated with chemotherapy with or without sequential low-dose rate half-body irradiation.
Best MP; Straw RC; Gumpel E; Fry DR
J Vet Intern Med; 2023; 37(6):2368-2374. PubMed ID: 37700548
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Bult JAA; Huisman F; Zhong Y; Veltmaat N; Kluiver J; Tonino SH; Vermaat JSP; Chamuleau MED; Diepstra A; van den Berg A; Plattel WJ; Brink M; Nijland M
Blood Cancer J; 2023 Sep; 13(1):130. PubMed ID: 37658062
[TBL] [Abstract][Full Text] [Related]
5. Hematological ratios and indices in canine large B-cell lymphoma.
Gavazza A; Cremonini V; Miglio A; Starita C; Rossi G; Antognoni MT
Open Vet J; 2024 Apr; 14(4):980-989. PubMed ID: 38808287
[TBL] [Abstract][Full Text] [Related]
6. Ayurveda Rasayana Therapy (ART) leads to tumor regression and increased survival in chemo-intolerance high-grade stage IV follicular lymphoma: A case study.
Bendale YN; Birari-Gawande P; Patil A; Kadam A
Clin Case Rep; 2024 Jun; 12(6):e8076. PubMed ID: 38827936
[TBL] [Abstract][Full Text] [Related]
7. Large granular lymphocyte lymphoma in 65 dogs (2005-2023).
Yale AD; Crawford AL; Gramer I; Guillén A; Desmas I; Holmes EJ
Vet Comp Oncol; 2024 Mar; 22(1):115-124. PubMed ID: 38156420
[TBL] [Abstract][Full Text] [Related]
8. Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?
Koff JL; Flowers CR
Cancer; 2017 Sep; 123(17):3222-3225. PubMed ID: 28464215
[No Abstract] [Full Text] [Related]
9. Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer.
Wang Y; Pattarayan D; Huang H; Zhao Y; Li S; Wang Y; Zhang M; Li S; Yang D
Res Sq; 2023 Sep; ():. PubMed ID: 37790509
[TBL] [Abstract][Full Text] [Related]
10. Role of interim PET/CT as predictor of outcome in newly diagnosed diffuse large b-cell lymphoma in the chemo-immunotherapy era.
Damlaj M; Jaber W; Al Najjar A; Altamimi S; Al Onazi T; Alzayed M; Damlaj A; Yassin R; Alahmari B; Alhejazi A; Gmati G; Abuelgasim K; Salama H; Alaskar A; Al Zahrani M
Curr Res Transl Med; 2023; 71(3):103406. PubMed ID: 37542921
[No Abstract] [Full Text] [Related]
11. A "two-hit" (chemo)therapy to improve checkpoint inhibition in cancer.
Falvo P; Orecchioni S; Raveane A; Mitola G; Bertolini F
Oncoscience; 2021; 8():55-57. PubMed ID: 33997109
[No Abstract] [Full Text] [Related]
12. Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial.
Haverkos B; Zain J; Kamdar M; Neuwelt A; Davila E; Bradeen X; Major A; Bair S; Jasem J; Smith C; Abbott D; Porcu P
Blood Adv; 2024 Feb; 8(3):708-711. PubMed ID: 38150586
[TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of the canine osteosarcoma vaccine, live Listeria vector.
Musser ML; Berger EP; Tripp CD; Clifford CA; Bergman PJ; Johannes CM
Vet Comp Oncol; 2021 Mar; 19(1):92-98. PubMed ID: 32729979
[TBL] [Abstract][Full Text] [Related]
14. RNA disruption indicates CHOP therapy efficacy in canine lymphoma.
Parissenti AM; Pritzker LB; Guo B; Narendrula R; Wang SX; Lin LL; Pei J; Skowronski K; Bienzle D; Woods JP; Pritzker KPH; Coomber BL
BMC Vet Res; 2019 Dec; 15(1):453. PubMed ID: 31842875
[TBL] [Abstract][Full Text] [Related]
15. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum.
MacEwen EG; Patnaik AK; Harvey HJ; Hayes AA; Matus R
Cancer Invest; 1986; 4(5):397-402. PubMed ID: 3801954
[TBL] [Abstract][Full Text] [Related]
16. The Genetic and Molecular Basis for Canine Models of Human Leukemia and Lymphoma.
Avery AC
Front Oncol; 2020; 10():23. PubMed ID: 32038991
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of non-neoplastic lymphocytes in lymph node aspirates from dogs with diffuse large B-cell lymphoma treated with chemo-immunotherapy.
Martini V; Aresu L; Riondato F; Marconato L; Cozzi M; Stefanello D; Comazzi S
Res Vet Sci; 2019 Aug; 125():130-135. PubMed ID: 31212200
[TBL] [Abstract][Full Text] [Related]
18. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment.
Mizuno T; Kato Y; Kaneko MK; Sakai Y; Shiga T; Kato M; Tsukui T; Takemoto H; Tokimasa A; Baba K; Nemoto Y; Sakai O; Igase M
Sci Rep; 2020 Jul; 10(1):11476. PubMed ID: 32651429
[TBL] [Abstract][Full Text] [Related]
19. Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma.
Aresu L; Agnoli C; Nicoletti A; Fanelli A; Martini V; Bertoni F; Marconato L
Front Vet Sci; 2021; 8():647009. PubMed ID: 33816589
[TBL] [Abstract][Full Text] [Related]
20. Assessment of neutrophil function in canine cancer patients undergoing chemotherapy and correlation with neutrophil numbers.
Ravanbakhsh A; Ahmed KA; MacDonald-Dickinson V; Fernandez NJ; Meachem MD; Dickinson RM
Can J Vet Res; 2021 Apr; 85(2):137-144. PubMed ID: 33883822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
